Redwood Shores, CA (PRWEB) September 02, 2014
Model N, Inc. (NYSE: MODN), the leading revenue management solutions provider to the life science and technology industries, announced today that David Bonnette, Chief Executive Officer of Lanyon, has been appointed to its Board of Directors, effective August 29th, 2014. Bonnette will replace Jay Larson who is resigning from the board.
Prior to joining Lanyon, Bonnette served as CEO at BigMachines for three years establishing the company as the leader in the Configure, Price and Quote (CPQ) market and delivering record-setting results leading to an acquisition by Oracle. Before that, he held a variety of executive roles at Oracle where he led North American organizations in ERP, CRM, and consulting. Bonnette has worked in the software industry for nearly 20 years while serving on the Boards of Directors of both BigMachines and Brainware (acquired by Lexmark).
“We welcome David to the Model N Board of Directors,” said Zack Rinat, Founder, Chairman of the Board of Directors, and Chief Executive Officer of Model N. “David brings extraordinary experience in CPQ, CRM and ERP, with deep business acumen and we are excited to have him on the Board. Model N is revolutionizing Revenue Management and with the growth of our Revvy SaaS platform, David’s insights and expertise in this category will be invaluable to us. I also want to thank Jay for his service and contributions he has made to Model N’s growth.”
“I am excited to join the Board at this point in the company’s growth,” said Bonnette. “Model N delivers mission critical Revenue Management solutions globally and their team has a strong vision, innovation and is fundamentally transforming how companies manage their topline. I am honored to join a great team and looking forward to accelerated growth of the business and this category.”
Bonnette is a member of Young Presidents’ Organization and regularly mentors entrepreneurs. He lives in the Dallas area with his wife and three children.
About Model N
Model N is the leader in Revenue Management solutions. Model N helps its customers maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Science and Technology companies across more than 100 countries. Global Customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.
Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.